When it comes to buying an experienced cancer drug specialist, a bidding war is naturally expected. But in the case of Pfizer’s $11 billion deal for Array BioPharma, that didn’t happen. Still, it didn ...
Everlaw, the cloud-native investigation and litigation platform, today announced its partnership with Array, a leading litigation support firm. Through the collaboration, Array will incorporate ...
Jason Owen claimed Martin Toha, the CEO of the credit data startup Array, promised him a large equity stake. A judge threw out Owen's case, saying the former chief strategy officer should've gotten it ...
In the latest trading session, Array Technologies, Inc. (ARRY) closed at $7.97, marking a -1.73% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.12%. At ...